πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 71 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9315463

Cyclohexylamine derivatives having Ξ²2 adrenergic agonist and M3 muscarinic antagonist acti

Almirall, S.A. Β· Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9254262

Dosage and formulation

Almirall, S.A. Β· Granted Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9233108

Cyclohexylamine derivatives having Ξ²2 adrenergic agonist and M3 muscarinic antagonist acti

Almirall, S.A. Β· Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9206183

Substituted pyrazolo[1,5-a]pyridines as JAK inhibitors

Almirall, S.A. Β· Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9133200

Imidazo[1,2-b]pyridazine and imidazo[4,5-b]pyridine derivatives as JAK inhibitors

Almirall, S.A. Β· Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9108918

Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl

Almirall, S.A. Β· Granted Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9056100

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. Β· Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9034311

Pyridin-2(1 H)-one derivatives as JAK inhibitors

Almirall, S.A. Β· Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8865728

Combinations comprising methotrexate and DHODH inhibitors

Almirall, S.A. Β· Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8802699

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. Β· Granted Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8772288

Substituted spiro[cycloalkyl-1,3β€²-indo]-2β€²(1β€²H)-one derivatives and their use as P38 mitog

Almirall, S.A. Β· Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8563731

Mesylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]jamino}-1-hydroxyethyl)-8-hyd

Almirall, S.A. Β· Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8536165

Azabiphenylaminobenzoic acid derivatives as DHODH inhibitors

Almirall, S.A. Β· Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8524908

Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethy

Almirall, S.A. Β· Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8513279

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. Β· Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8501943

Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid a

Almirall, S.A. Β· Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8450341

Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibi

Almirall, S.A. Β· Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8420669

Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the BETA2 adrenergic recept

Laboratories Almirall, S.A. Β· Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8334294

4,8-diphenyl-polyazanaphthalene derivatives

Almirall, S.A. Β· Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8283342

Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8

Almirall, S.A. Β· Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8258308

Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors

Laboratories Almirall, S.A. Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8258122

3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives

Almirall, S.A. Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8242177

Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the Ξ²2 adrenergic receptor

Almirall, S.A. Β· Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8178679

Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the Ξ²2 adrenergic receptors

Almirall, S.A. Β· Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted